Rheumatoid Arthritis Drugs Market Size was US$ 26.3 Billion in 2021. Industry Trends, Growth, Insight, Impact of COVID-19, Company Analysis, Global Forecast 2022-2027.
Rheumatoid Arthritis Drugs Market, Size, Global Forecast 2022-2027
Rheumatoid Arthritis Drugs Market is estimated to reach US$ 34.3 Billion by 2027. Rheumatoid arthritis is a disease that induces pain and inflammation in joints. It influences individuals of all ages; notwithstanding, the geriatric population is highly susceptible to developing this disorder. The symptoms of rheumatoid arthritis embrace pain, stiffness, tenderness, and swelling of joints. Currently, no cure is available for rheumatoid arthritis. Despite this, certain drugs are used to efficiently control the conditions of rheumatoid arthritis, which include disease-modifying anti-rheumatic drugs (DMARDs), non-steroidal anti-inflammatory drugs (NSAIDs), corticosteroids, and uric acid drugs.
